Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Lipid Res ; 41(11): 1740-51, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11060343

ABSTRACT

Peroxisome proliferator-activated receptors (PPARs) are activated by a variety of fatty acids, eicosanoids, and hypolipidemic and insulin-sensitizing drugs. Many of these compounds bind avidly to members of a family of small lipid-binding proteins, the fatty acid-binding proteins (FABPs). Fatty acids are activated to CoA esters, which bind with high affinity to the acyl-CoA-binding protein (ACBP). Thus, the availability of known and potential PPAR ligands may be regulated by lipid-binding proteins. In this report we show by transient transfection of CV-1 cells that coexpression of ACBP and adipocyte lipid-binding protein (ALBP) exerts a ligand- and PPAR subtype-specific attenuation of PPAR-mediated trans-activation, suggesting that lipid-binding proteins, when expressed at high levels, may function as negative regulators of PPAR activation by certain ligands. Expression of ACBP, ALBP, and keratinocyte lipid-binding protein (KLBP) is induced during adipocyte differentiation, a process during which PPARgamma plays a prominent role. We present evidence that endogenous ACBP, ALBP, and KLBP not only localize to the cytoplasm but also exhibit a prominent nuclear localization in 3T3-L1 adipocytes. In addition, forced expression of ACBP, ALBP, and KLBP in CV-1 cells resulted in a substantial accumulation of all three proteins in the nucleus. These results suggest that lipid-binding proteins, contrary to the general assumption, may exert their action in the nucleus as well as in the cytoplasm.


Subject(s)
Carrier Proteins/physiology , Ligands , Neoplasm Proteins , Nerve Tissue Proteins , Receptors, Cytoplasmic and Nuclear/physiology , Transcription Factors/physiology , Transcriptional Activation , 3T3 Cells , Adipocytes/ultrastructure , Animals , Carrier Proteins/analysis , Carrier Proteins/genetics , Cell Differentiation , Cell Line , Cell Nucleus/chemistry , Cytoplasm/chemistry , Diazepam Binding Inhibitor , Fatty Acid-Binding Protein 7 , Fatty Acid-Binding Proteins , Gene Expression , Mice , Transfection
2.
J Biol Chem ; 273(37): 23897-903, 1998 Sep 11.
Article in English | MEDLINE | ID: mdl-9727003

ABSTRACT

Several lines of evidence have recently underscored the significance of fatty acids or fatty acid-derived metabolites as signaling molecules in adipocyte differentiation. The acyl-CoA-binding protein (ACBP), which functions as an intracellular acyl-CoA pool former and transporter, is induced during adipocyte differentiation. In this report we describe the effects of expression of high levels of ACBP antisense RNA on the differentiation of 3T3-L1 cells. Pools of 3T3-L1 cells transfected with vectors expressing ACBP antisense RNA showed significantly less lipid accumulation as compared with cells transfected with the control vector. When individual clones were analyzed the degree of differentiation at day 10 was inversely correlated with the level of ACBP antisense RNA expression at day 0. Furthermore, in the clones with the highest levels of ACBP antisense expression, the induction of expression of the adipogenic transcription factors peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding protein alpha as well as several adipocyte-specific genes was significantly delayed and reduced. The adipogenic potential of antisense-expressing cells was partially restored by transfection with a vector expressing high levels of ACBP. Taken together, these results are strong evidence that inhibition of differentiation is causally related to the decreased expression of ACBP, indicating that ACBP plays an important role during adipocyte differentiation.


Subject(s)
Adipocytes/cytology , Adipocytes/metabolism , Carrier Proteins/genetics , RNA, Antisense/metabolism , Thiazolidinediones , 1-Methyl-3-isobutylxanthine/pharmacology , 3T3 Cells , Animals , CCAAT-Enhancer-Binding Proteins , Carrier Proteins/biosynthesis , Cell Differentiation , Clone Cells , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Dexamethasone/pharmacology , Diazepam Binding Inhibitor , Gene Expression Regulation/drug effects , Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Mice , Nuclear Proteins/biosynthesis , Nuclear Proteins/genetics , RNA, Messenger/genetics , Receptors, Cytoplasmic and Nuclear/biosynthesis , Receptors, Cytoplasmic and Nuclear/genetics , Recombinant Proteins/biosynthesis , Rosiglitazone , Thiazoles/pharmacology , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transcription, Genetic , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL